Determination of the androgen receptor status of circulating tumour cells in metastatic breast cancer patients

Determination of the androgen receptor status of circulating tumour cells in metastatic breast cancer patients

Abstract Background The prognostic relevance of circulating tumour cells (CTCs) in metastatic breast cancer (MBC) patients has been confirmed by several clinical trials. However, predictive blood-based biomarkers for stratification of patients for targeted therapy are still lacking. The DETECT studi...

Full description

Bibliographic Details
Main Authors: Natalia Krawczyk, Melissa Neubacher, Franziska Meier-Stiegen, Hans Neubauer, Dieter Niederacher, Eugen Ruckhäberle, Svjetlana Mohrmann, Jürgen Hoffmann, Thomas Kaleta, Malgorzata Banys-Paluchowski, Petra Reinecke, Irene Esposito, Wolfgang Janni, Tanja Fehm
Format: Article
Language:English
Published: BMC 2019-11-01
Series:BMC Cancer
Subjects:
Predictive marker
Androgen receptor
Metastatic breast cancer
Circulating tumour cells
Online Access:http://link.springer.com/article/10.1186/s12885-019-6323-8

Similar Items

Similar Items